The largest database of trusted experimental protocols

Ultrapure escherichia coli 0111 b4 lps free of lipoproteins

Manufactured by Thermo Fisher Scientific
Sourced in United States

Ultrapure Escherichia coli 0111:B4 LPS, free of lipoproteins, is a laboratory product designed to provide a consistent, high-quality source of lipopolysaccharide (LPS) from the Escherichia coli O111:B4 strain. This product is rigorously purified to remove lipoproteins, ensuring a well-defined LPS preparation for research applications.

Automatically generated - may contain errors

2 protocols using ultrapure escherichia coli 0111 b4 lps free of lipoproteins

1

Differentiation of THP-1 Monocytes into Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP1 monocytes obtained from ATCC were differentiated into macrophage using 100 nM phorbol myristate acetate (PMA) for 5 h in RPMI 1640 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin and 10 % fetal bovine serum (FBS) (Sigma). Ultrapure Escherichia coli 0111:B4 LPS free of lipoproteins was obtained from Invitrogen (San Diego, CA).
+ Open protocol
+ Expand
2

Hydrogen Sulfide Modulates LPS-Induced Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tamm-Horsfall protein 1 (THP-1) cells were maintained in RPMI-1640 supplemented with 2 mm l-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin and 10% fetal bovine serum (FBS; Sigma, St. Louis, MO, USA). Ultrapure Escherichia coli 0111:B4 LPS free of lipoproteins was obtained from Invitrogen (San Diego, CA, USA). The cells were plated in 22-mm tissue culture dishes (2×106 cells/dish). Macrophage differentiation was induced with phorbol myristate acetate (PMA, 100 nM) for 5 h. In one set of experiments (pre-treatment experiments) the effects of H2S were examined following a 30-min pre-treatment with sodium hydrosulfide (NaHS, an H2S donor) (Sigma) at 0.01, 0.1, 0.5 or 1 mM followed by a washout, followed by incubation with bacterial lipopolysaccharide (LPS, 1 μg/ml) in 1% FSB RPMI-1640 for 1, 4, 8 or 24 h. In another set of experiments (co-treatment experiments), NaHS was administered 30 min prior to the LPS administration, without a washout. The control cells were maintained in 1% FBS RPMI-1640.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!